Svas Biosana S.p.A. (BIT: SVS)
Italy
· Delayed Price · Currency is EUR
7.50
0.00 (0.00%)
Jan 17, 2025, 9:00 AM CET
Svas Biosana Revenue
Svas Biosana had revenue of 59.04M EUR in the half year ending June 30, 2024, with 32.10% growth. This brings the company's revenue in the last twelve months to 123.79M, up 10.82% year-over-year. In the year 2023, Svas Biosana had annual revenue of 121.63M with 22.22% growth.
Revenue (ttm)
123.79M
Revenue Growth
+10.82%
P/S Ratio
n/a
Revenue / Employee
378.56K
Employees
323
Market Cap
39.41M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
Dec 31, 2019 | 100.49M | 6.32M | 6.71% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.27B |
Amplifon | 2.36B |
DiaSorin | 1.18B |
EL.En. | 665.50M |
Philogen | 3.92M |
Pharmanutra | 113.13M |
Safilo Group | 1.01B |
GPI S.p.A. | 484.01M |